Stoneridge (SRI) Q4 2023 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2023 earnings summary
31 Oct, 2026Executive summary
FY 2023 adjusted sales grew 14.2% to $961.2M and adjusted EBITDA rose to $48.1M; adjusted EPS was $(0.08).
Q4 adjusted EPS was $0.12; adjusted EBITDA was $15.6M, or 6.8% of adjusted sales.
2028 targets are revenue of $1.35B–$1.55B and EBITDA margin of 12%–14%.
Financial highlights
FY reported net sales were $975.8M vs. $899.9M in 2022; adjusted sales were $961.2M vs. $841.5M, up 14.2%.
FY adjusted gross profit was $202.1M at 21.0% margin; adjusted operating income was $16.2M at 1.7% margin, vs. $2.7M and 0.3% in 2022.
FY adjusted EBITDA rose to $48.1M from $29.8M, with margin increasing to 5.0% from 3.5%; reported net loss was $5.2M and reported EPS $(0.19).
Q4 reported sales were $229.5M; adjusted sales were $229.4M. Adjusted operating income was $6.2M at 2.7% margin, and adjusted gross profit was $45.7M at 19.9%.
FY net loss was $5.2M, or $0.19 per share, compared with a $14.1M net loss, or $0.52 per share, in 2022.
Outlook and guidance
2024 guidance: sales of $990M–$1.01B, adjusted gross margin of 22.0%–22.75%, operating margin of 2.75%–3.25%, EPS of $0.30–$0.40 and EBITDA of $64M–$70M, or 6.5%–6.9% of sales.
Guidance midpoint is $1.0B revenue and $67M EBITDA, with a 6.7% EBITDA margin and 170 bps margin expansion vs. 2023.
Revenue midpoint implies ~4% growth while weighted-average OEM end markets are expected to decline ~5%; MirrorEye and Smart 2 tachograph launches are expected growth drivers.
Expected EBITDA margin expansion is 150–190 bps, supported by revenue growth, gross-margin improvement, cost actions and operating leverage.
2028 targets are revenue of $1.35B–$1.55B and EBITDA margin of 12%–14%; midpoint targets are $1.45B revenue and 13% margin.
Latest events from Stoneridge
- Q2 margin recovery, lower net debt and major awards support reaffirmed 2026 guidance.SRI
Corporate presentation - Q2 2026 revenue up 15.1%, net loss narrowed, and guidance reaffirmed on strong vehicle demand.SRI
Q2 2026 - Growth driven by MirrorEye, regulatory tailwinds, and operational improvements amid macro softness.SRI
Stephens 26th Annual Investment Conference | NASH2024 - All proposals, including director elections and compensation, were approved without shareholder questions.SRI
AGM 2026 - Q1 2026 saw 9.2% sales growth, margin gains, record MirrorEye sales, and net debt reduction.SRI
Q1 2026 - Annual meeting covers director elections, auditor ratification, compensation, and ESG oversight.SRI
Proxy filing - Annual meeting covers director elections, auditor ratification, and incentive plan amendment.SRI
Proxy filing - Sales and earnings fell on market weakness, but MirrorEye and cash flow showed improvement.SRI
Q3 2024 - Q2 2024 delivered margin gains and improved profitability, with key OEM launches accelerating.SRI
Q2 2024